<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00991679</url>
  </required_header>
  <id_info>
    <org_study_id>I-2007-12-111</org_study_id>
    <nct_id>NCT00991679</nct_id>
  </id_info>
  <brief_title>CXCL9, CXCL10, CXCL11, and CXCR3 in Dry Eye Syndrome</brief_title>
  <official_title>Expression of CXCL9, CXCL10, CXCL11, and CXCR3 in the Tear Film and Ocular Surface of Patients With Dry Eye Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chonnam National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chonnam National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the expression of CXCL9, CXCL10, CXCL11, and CXCR3 in
      the tear film and ocular surface of patients with dry eye syndrome.

      Thirty-three patients with dry eye (16 Sjögren's syndrome and 17 non-Sjögren's syndrome
      patients) and 15 control subjects were recruited. The concentrations of CXCL9, CXCL10, and
      CXCL11 in tears were measured using enzyme-linked immunosorbent assay. The correlation
      between chemokine levels and tear film and ocular surface parameters was analyzed. Expression
      of CXCL9, CXCL10, CXCL11, and CXCR3 in the conjunctiva was evaluated using
      immunohistochemistry. Flow cytometry was performed to count CXCR3+ cells and CXCR3+CD4+ cells
      in the conjunctiva.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">48</enrollment>
  <condition>Dry Eye Syndrome</condition>
  <arm_group>
    <arm_group_label>Normal control subjects</arm_group_label>
    <description>Normal control subjects who did not show the clinical symptom and findings of dry eye syndrome.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>dry eye patients</arm_group_label>
    <description>Patients with dry eye syndrome who had symptoms of dry eye for more than 3 months, low tear film break up time (BUT, ≤7 sec), low Schirmer test (&lt;10 mm), low tear clearance rate (&lt;8X), and positive fluorescein or rose bengal vital staining (≥3) and were not treated with anti-inflammatory agents such as topical cyclosporine or steroids were included in the study.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      tears, conjunctiva
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Primary care clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinical diagnosis of dry eye syndrome

        Exclusion Criteria:

          -  active ocular infection or inflammation not associated with dry eye

          -  drug toxicity

          -  contact lens wear

          -  ocular allergy

          -  ocular surgery within the last 3 months

          -  lid or lash abnormalities
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>24 Years</minimum_age>
    <maximum_age>77 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kyung-Chul Yoon, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Ophthalmology, Chonnam National University Medical School and Hospital, Gwangju, South Korea</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chonnam National University Hospital</name>
      <address>
        <city>Gwangju</city>
        <state>Chonnam</state>
        <zip>501-757</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <results_reference>
    <citation>Yoon KC, De Paiva CS, Qi H, Chen Z, Farley WJ, Li DQ, Pflugfelder SC. Expression of Th-1 chemokines and chemokine receptors on the ocular surface of C57BL/6 mice: effects of desiccating stress. Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2561-9.</citation>
    <PMID>17525185</PMID>
  </results_reference>
  <results_reference>
    <citation>Wallace GR, John Curnow S, Wloka K, Salmon M, Murray PI. The role of chemokines and their receptors in ocular disease. Prog Retin Eye Res. 2004 Jul;23(4):435-48. Review.</citation>
    <PMID>15219876</PMID>
  </results_reference>
  <results_reference>
    <citation>Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca. Curr Eye Res. 1999 Sep;19(3):201-11.</citation>
    <PMID>10487957</PMID>
  </results_reference>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 7, 2009</study_first_submitted>
  <study_first_submitted_qc>October 7, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 8, 2009</study_first_posted>
  <last_update_submitted>October 7, 2009</last_update_submitted>
  <last_update_submitted_qc>October 7, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 8, 2009</last_update_posted>
  <responsible_party>
    <name_title>Kyung-Chul Yoon, MD/ Assisted professor</name_title>
    <organization>Department of Ophthalmology, Chonnam National University Medical School and Hospital, Gwangju, South Korea</organization>
  </responsible_party>
  <keyword>Dry eye syndrome</keyword>
  <keyword>CXCL9 chemokine</keyword>
  <keyword>CXCL10 chemokine</keyword>
  <keyword>CXCL11 chemokine</keyword>
  <keyword>CXCR3 receptor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
    <mesh_term>Dry Eye Syndromes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

